Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets

Biomaterials

Volumn 24, Issue 2, 2003, Pages 305-312

  De Vos, Paul ^a   Van Hoogmoed, Chris G ^a   Van Zanten, Jacoba ^a   Netter, S ^a   Strubbe, Jan H ^a   Busscher, Henk J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Alginate; Biocompatibility; Encapsulation; Insulin; Islets; Microencapsulation

Indexed keywords

BIOCOMPATIBILITY; CELLS; ENCAPSULATION; GRAFTS; TRANSPLANTATION (SURGICAL);

MICROCAPSULES;

BIOMATERIALS;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CHEMICAL ANALYSIS; GRAFT SURVIVAL; IMMUNITY; IMPLANTATION; MALE; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; ANIMAL; CHEMISTRY; DRUG FORMULATION; ELECTRON PROBE MICROANALYSIS; PANCREAS ISLET; PHYSIOLOGY;

BIOMATERIAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG COMPOUNDING; ELECTRON PROBE MICROANALYSIS; ISLETS OF LANGERHANS; MALE; RATS;

EID: 0037209858     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00319-8     Document Type: Article

References (35)

1. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., Kneteman N.M., Rajotte R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 343:2000;230-238.
2. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-910.
3. Hasse C., Klöck G., Schlosser A., Zimmermann U., Rothmund M. Parathyroid allotransplantation without immunosuppression. Lancet. 350:1997;1296-1297.
4. Soon-Shiong P., Feldman E., Nelson R., Komtebedde J., Smidsrod O., Skjåk-Bræk G., Espevik T., Heintz R., Lee M. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation. 54(5):1992;769-774.
5. Fritschy W.M., De Vos P., Groen H., Klatter F.A., Pasma A., Wolters G.H., Van Schilfgaarde R. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transplant Int. 7:1994;264-271.
6. Sun Y.L., Ma X.J., Zhou D.B., Vacek I., Sun A.M. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 98:1996;1417-1422.
7. O'Shea G.M., Goosen M.F.A., Sun A.M. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta. 804:1984;133-136.
8. De Vos P., De Haan B.J., Wolters G.H.J., Strubbe J.H., Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia. 40:1997;262-270.
9. De Vos P., Wolters G.H., Fritschy W.M., Van Schilfgaarde R. Obstacles in the application of microencapsulation in islet transplantation. Int J Artif Org. 16:1993;205-212.
10. De Vos P., Wolters G.H.J., Van Schilfgaarde R. Possible relationship between fibrotic overgrowth of alginate- polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity. Transplant Proc. 26:1994;782-783.
11. De Vos P., De Haan B., Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials. 18:1997;273-278.
12. De Vos P., van Straaten J.F., Nieuwenhuizen A.G., de Groot M., Ploeg R.J., De Haan B.J., Van Schilfgaarde R. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes. 48:1999;1381-1388.
13. De Vos P., De Haan B.J., Pater J., Van Schilfgaarde R. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation. 62:1996;893-899.
14. De Vos P., De Haan B.J., Wolters G.H.J., Van Schilfgaarde R. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation. 62:1996;888-893.
15. Steffens A.B. A method for frequent sampling of blood and continuous infusion of fluids in the rat without disturbing the animal. Physiol Behav. 4:1969;833-836.
16. De Vos P., Vegter D., De Haan B.J., Strubbe J.H., Bruggink J.E., Van Schilfgaarde R. Kinetics of intraperitoneally infused insulin in rats. functional implications for the bioartificial pancreas Diabetes. 45:1996;1102-1107.
17. Wolters G.H., van Suylichem P.T., Van Deijnen J.H., Van Schilfgaarde R. Factors influencing the isolation process of islets of Langerhans. Horm Metab Res Suppl. 25:1990;20-26.
18. van Suylichem P.T., Wolters G.H., Van Schilfgaarde R. The efficacy of density gradients for islet purification. a comparison of seven density gradients Transplant Int. 3:1990;156-161.
19. Wolters G.H.J., Fritschy W.M., Gerrits D., Van Schilfgaarde R. A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. J Appl Biomater. 3:1992;281-286.
20. Fritschy W.M., Wolters G.H., Van Schilfgaarde R. Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes. 40:1991;37-43.
21. De Vos P., De Haan B.J., Van Schilfgaarde R. Upscaling the production of encapsulated islets. Biomaterials. 18:1997;1085-1090.
22. Fritschy W.M., Gerrits P.O., Wolters G.H., Pasma A., Van Schilfgaarde R. Glycol methacrylate embedding of alginate-polylysine microencapsulated pancreatic islets. Biotech Histochem. 70:1995;188-193.
23. Thu B., Bruheim P., Espevik T., Smidrod O., Soon-Shiong P., Skjak-Braek G. Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials. 17:1996;1031-1040.
24. Sun A.M. Advantages of microencapsulation as an immunoprotection method in the transplantation of pancreatic islets. Ann Transplant. 2:1997;55-62.
25. Bodziony J. Bioartificial endocrine pancreas. foreign-body reaction and effectiveness of diffusional transport of insulin and oxygen after long-term implantation of hollow fibers into rats Res Exp Med Berl. 192:1992;305-316.
26. Clayton H.A., London N.J.M., Colloby P.S., Bell P.R.F., James R.F.L. A study of the effect of capsules composition on the viability of cultured alginate/poly-L-lysine-encapsulated rat islets. Diabetes Res. 14:1990;127-132.
27. Klock G., Pfeffermann A., Ryser C., Grohn P., Kuttler B., Hahn H.J., Zimmermann U. Biocompatibility of mannuronic acid-rich alginates. Biomaterials. 18:1997;707-713.
28. Soon-Shiong P., Otterlei M., Skjåk-Brćk G., Smidsrod O., Heintz R., Lanza R.P., Espevik T. An immunological basis for the fibrotic reaction to implanted microcapsules. Transplant Proc. 23:1991;758-759.
29. Klock G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., Wohrle M., Federlin K., Zimmermann U. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol. 40:1994;638-643.
30. Gotfredsen C.F., Stewart M.G., O'Shea G.M., Vose J.R., Horn T., Moody A.J. The fate of transplanted encapsulated islets in spontaneously diabetic BBWOR rats. Diabetes Res. 15:1990;157-163.
31. Dupuy B., Arien A., Perrot Minnot A. FI-IR of membranes made with alginate-polylysine complexes. Variations with mannuronic or guluronic content of the polysaccharides. Art Cell Blood Subs Imm Biotech. 22:1994;71-82.
32. Thu B., Bruheim P., Espevik T., Smidrod O., Soon-Shiong P., Skjak-Break G. Alginate polycation microcapsules II. Some functional properties. Biomaterials. 17:1996;1069-1079.
33. Bystricky S., Malovikova A., Sticzay T. Interaction of acid polysaccharides with polylysine enantiomers, conformation probe in solution. Carbohydr Polym. 15:1991;299-308.
34. Bystricky S., Malovikova A., Sticzay T. Interaction of alginate and pectins with cationic polypeptides. Carbohydr Res. 13:1990;283-294.
35. Smidsrod O., Skjak-Break G. Alginate as immobilization matrix for cells. Trends Biotechnol. 8:1990;71-78.